Status:
TERMINATED
Prehab Prior to Undergoing Tricuspid Intervention
Lead Sponsor:
Baylor Research Institute
Conditions:
Tricuspid Valve Disease
Tricuspid Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
This study will aim to standardize the prehabilitation protocol to optimize patients and document the clinical and echo variables that could improve clinical outcomes of tricuspid valve intervention.
Detailed Description
Prior to screening activities, each subject will be given an opportunity to ask questions and to understand the details of study participation. Subjects who meet the inclusion and exclusion criteria a...
Eligibility Criteria
Inclusion
- ≥ 18 years of age
- Moderate-Severe or Severe TR
- Undergoing tricuspid valve surgical or catheter-based intervention
Exclusion
- 1\. Clinical instability according to the judgement of the Investigator
Key Trial Info
Start Date :
October 25 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT04665583
Start Date
October 25 2020
End Date
November 1 2021
Last Update
September 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Baylor Scott & White Heart Hospital - Plano
Plano, Texas, United States, 75093